|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 9/10 | |
| A61K 47/10 | |||
| A61K 31/5513 | |||
| A61P 25/18 | |||
| A61K 47/02 |
| (11) | Patento numeris | 1646393 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04748853.1 |
| Europos patento paraiškos padavimo data | 2004-07-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-04-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-09-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/NZ2004/000158 |
| Data | 2004-07-22 |
| (87) | Numeris | WO 2005/007168 |
| Data | 2005-01-27 |
| (30) | Numeris | Data | Šalis |
| 52714203 | 2003-07-23 | NZ |
| (72) |
SURMAN, Peter William, NZ
HOULDER-LEVELL, Sharon, NZ
MAK, Wai Bik, NZ
MCLEOD, Andrew Douglas, NZ
|
| (73) |
Douglas Pharmaceuticals Limited,
Central Park Drive, Lincoln, Auckland,
NZ
|
| (54) | A STABLE CLOZAPINE SUSPENSION FORMULATION |
| A STABLE CLOZAPINE SUSPENSION FORMULATION |